0001209191-17-053206.txt : 20170918 0001209191-17-053206.hdr.sgml : 20170918 20170918174646 ACCESSION NUMBER: 0001209191-17-053206 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170915 FILED AS OF DATE: 20170918 DATE AS OF CHANGE: 20170918 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Haqq Christopher CENTRAL INDEX KEY: 0001612095 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36548 FILM NUMBER: 171090608 MAIL ADDRESS: STREET 1: C/O ATARA BIOTHERAPEUTICS, INC. STREET 2: 3260 BAYSHORE BOULEVARD CITY: BRISBANE STATE: CA ZIP: 94005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Atara Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001604464 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 460920988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 611 GATEWAY BLVD STREET 2: SUITE 900 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-278-8930 MAIL ADDRESS: STREET 1: 611 GATEWAY BLVD STREET 2: SUITE 900 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-09-15 0 0001604464 Atara Biotherapeutics, Inc. ATRA 0001612095 Haqq Christopher 611 GATEWAY BOULEVARD SUITE 900 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 EVP, R&D & Chief Scientific Of Common Stock 2017-09-15 4 S 0 6000 15.30 D 349305 D Common Stock 17312 I See footnote Common Stock 2688 I See footnote Transaction pursuant to Rule 10b5-1 Plan adopted September 27, 2016. The shares are held by the Chris Haqq 2014 GRAT, of which the Reporting Person is trustee. The shares are held by The Havenside Trust, of which the Reporting Person is trustee. /s/ Tina Gullotta, Attorney-in-Fact for Christopher Haqq 2017-09-18